Advisory Research’s Danimer Scientific, Inc. DNMR Stock Holding History

Advisory Research’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,384	Closed	-$163K	–	413
2022 Q3	$163K	Buy	+1,384	New	+$247K	0.02%	319
2021 Q3	–	Sell	-839	Closed	-$841K	–	418
2021 Q2	$841K	Buy	839 +630	+301%	+$628K	0.06%	226
2021 Q1	$316K	Buy	+209	New	+$339K	0.02%	302

Other funds holding DNMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Advisory Research's DNMR Position: Q4 2022 in Review

Advisory Research sold out of Danimer Scientific, Inc. (DNMR) in Q4 2022, closing a stake of 1,384 shares — an estimated $163K sold.

Advisory Research first reported a position in DNMR in Q1 2021 and held it in 3 quarters. The position peaked at $841K in Q2 2021. 176 funds tracked by Wall St. Rank hold DNMR as of Q4 2022.

Advisory Research reported no remaining Danimer Scientific, Inc. position as of Q4 2022 after selling out during the quarter.
Advisory Research sold 1,384 Danimer Scientific, Inc. shares in Q4 2022, an estimated $163K.
Advisory Research first reported a position in Danimer Scientific, Inc. in Q1 2021 and held it in 3 quarters.
Advisory Research's Danimer Scientific, Inc. position peaked at $841K in Q2 2021.
176 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2022.

Based on Advisory Research's 13F filing for Q4 2022, filed 13 Feb 2023.